Table 1.
Study cohort | Women | Men | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
65 years and older | ||||||
Baseline versus sign use 1–2 weeks | 2.23 | 0.80–6.18 | 0.12 | 11.00 | 1.47–81.92 | <0.01 |
Baseline versus sign use 3–4 weeks | 1.33 | 0.44–4.02 | 0.60 | 7.46 | 0.99–55.74 | <0.05 |
Baseline versus follow-up | 3.13 | 0.89–11.01 | 0.07 | 10.10 | 1.23–82.83 | <0.05 |
Under 65 years old | ||||||
Baseline versus sign use 1–2 weeks | 1.16 | 0.90–1.51 | 0.24 | 1.02 | 0.83–1.26 | 0.82 |
Baseline versus sign use 3–4 weeks | 1.35 | 1.04–1.76 | <0.05 | 1.32 | 0.08–1.63 | <0.01 |
Baseline versus follow-up | 1.04 | 0.80–1.36 | 0.74 | 1.08 | 0.88–1.33 | 0.43 |
Student | ||||||
Baseline versus sign use 1–2 weeks | 6.33 | 4.12–9.71 | <0.001 | 1.70 | 1.22–2.37 | <0.001 |
Baseline versus sign use 3–4 weeks | 2.74 | 1.76–4.26 | <0.001 | 1.80 | 1.32–2.47 | <0.001 |
Baseline versus follow-up | 0.69 | 0.40–1.19 | 0.19 | 0.48 | 0.32–0.73 | <0.001 |
OR Odds ratio; CI, confidence interval